omeprazole has been researched along with Plasmacytoma in 3 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Plasmacytoma: Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report on the clinical signs, diagnosis and 8-year course in a 54-year-old female patient with myeloma and gastrinoma with liver metastasis and associated Cushing syndrome treated for the last 3 years with the new H+/K+-ATPase inhibitor omeprazole which has successfully suppressed the massive gastric acid hypersecretion." | 8.77 | [Long-term suppression of acid secretion with omeprazole use in metastatic gastrinoma]. ( Kummer, H; Schaub, N; Schlup, M; Wegmann, W, 1988) |
| "We report on the clinical signs, diagnosis and 8-year course in a 54-year-old female patient with myeloma and gastrinoma with liver metastasis and associated Cushing syndrome treated for the last 3 years with the new H+/K+-ATPase inhibitor omeprazole which has successfully suppressed the massive gastric acid hypersecretion." | 4.77 | [Long-term suppression of acid secretion with omeprazole use in metastatic gastrinoma]. ( Kummer, H; Schaub, N; Schlup, M; Wegmann, W, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez Cueto, D | 1 |
| Bruno, S | 1 |
| Bustos Fernandez, LM | 1 |
| Narbaitz, M | 1 |
| Kato, K | 1 |
| Sugitani, M | 1 |
| Nagata, T | 1 |
| Nishinarita, S | 1 |
| Kawamura, F | 1 |
| Takahashi, Y | 1 |
| Ishii, Y | 1 |
| Kawamura, Y | 1 |
| Komuro, S | 1 |
| Yanai, M | 1 |
| Nemoto, N | 1 |
| Arakawa, Y | 1 |
| Schaub, N | 1 |
| Schlup, M | 1 |
| Kummer, H | 1 |
| Wegmann, W | 1 |
2 reviews available for omeprazole and Plasmacytoma
| Article | Year |
|---|---|
[Gastric solitary plasmacytoma associated with +Helicobacter pylori infection].
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastric Mucosa; Helicobacter I | 1999 |
[Long-term suppression of acid secretion with omeprazole use in metastatic gastrinoma].
Topics: Female; Gastric Juice; Gastrinoma; Humans; Liver Neoplasms; Middle Aged; Neoplasms, Multiple Primary | 1988 |
1 other study available for omeprazole and Plasmacytoma
| Article | Year |
|---|---|
A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Biopsy, Needle; Clarithromycin; Drug Therapy, | 2001 |